Enliven Therapeutics Ownership | Who Owns Enliven Therapeutics?
Enliven Therapeutics Ownership Summary
Enliven Therapeutics is owned by 128.23% institutional investors, 6.23% insiders. Fmr is the largest institutional shareholder, holding 16.36% of ELVN shares. Polar Capital Healthcare Opports Inc is the top mutual fund, with 4.93% of its assets in Enliven Therapeutics shares.
ELVN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Enliven Therapeutics | 128.23% | 6.23% | -34.46% |
| Sector | Healthcare Stocks | 247.07% | 12.15% | -159.22% |
| Industry | Biotech Stocks | 385.89% | 11.79% | -297.68% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 10.83M | 16.36% | $496.34M |
| Orbimed advisors | 6.78M | 10.79% | $343.91M |
| Polar capital | 6.43M | 10.24% | $326.35M |
| Blackrock funding, inc. /de | 5.71M | 8.63% | $261.84M |
| Vestal point capital, lp | 4.00M | 6.37% | $203.00M |
| Commodore capital lp | 3.27M | 5.21% | $166.21M |
| Price t rowe associates inc /md/ | 2.90M | 4.62% | $147.37M |
| Vanguard group | 2.80M | 4.51% | $43.15M |
| Vanguard capital management | 2.89M | 4.37% | $132.62M |
| Citadel advisors | 2.07M | 3.29% | $105.00M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Commodore capital lp | 3.27M | 9.90% | $166.21M |
| Orbimed advisors | 6.78M | 6.41% | $343.91M |
| Fairmount funds management | 1.86M | 6.22% | $94.17M |
| Tri locum partners lp | 866.72K | 5.41% | $43.99M |
| First turn management | 954.36K | 5.18% | $48.43M |
| Vestal point capital, lp | 4.00M | 4.74% | $203.00M |
| Avidity partners management lp | 550.00K | 4.47% | $27.91M |
| First light asset management | 1.36M | 4.20% | $69.06M |
| Exome asset management | 100.20K | 3.14% | $5.09M |
| Stempoint capital lp | 346.91K | 3.03% | $17.61M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Price t rowe associates inc /md/ | 2.90M | 0.01% | 2.81M |
| Polar capital | 6.43M | 0.77% | 1.36M |
| Blackrock funding, inc. /de | 5.71M | 0.00% | 1.35M |
| First light asset management | 1.36M | 4.20% | 1.16M |
| Adage capital partners gp | 1.08M | 0.08% | 1.08M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | 11.00K | 0.00% | -1.66M |
| Point72 asset management | - | - | -1.50M |
| Capital research global investors | - | - | -1.30M |
| Vr adviser | 526.33K | 0.81% | -1.20M |
| Orbimed advisors | 6.78M | 6.41% | -1.18M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Adage capital partners gp | 1.08M | 0.08% | 1.08M | $54.98M |
| Samlyn capital | 912.64K | 0.75% | 912.64K | $46.32M |
| Tri locum partners lp | 866.72K | 5.41% | 866.72K | $43.99M |
| Westfield capital management co lp | 766.55K | 0.12% | 766.55K | $35.14M |
| Principal financial group | 332.24K | 0.01% | 332.24K | $15.23M |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -7.00 |
| Mai capital management | -7.00 |
| Covestor | -15.00 |
| Td capital management | -16.00 |
| Stephens consulting | -20.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 218 | 21.11% | 80,527,066 | 29.07% | 128 | 1.06% | 153 | 18.60% | 48 | 45.45% |
| Mar 31, 2026 | 90 | -29.13% | 11,947,495 | -80.85% | 21 | 0.21% | 64 | -1.54% | 17 | -62.22% |
| Dec 31, 2025 | 85 | -36.09% | 19,456,209 | -67.24% | 31 | 0.34% | 42 | -46.84% | 34 | 13.33% |
| Sep 30, 2025 | 52 | -57.72% | 9,174,149 | -84.56% | 17 | 0.14% | 34 | -58.02% | 10 | -56.52% |
| Jun 30, 2025 | 122 | 0.83% | 59,425,065 | 19.12% | 114 | 1.14% | 80 | 23.08% | 23 | -30.30% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Polar Capital Healthcare Opports Inc | 3.61M | 4.93% | - |
| Polar Capital Biotech S Inc | 2.56M | 3.49% | - |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.11M | 2.87% | 218.04K |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.88M | 2.64% | 276.54K |
| Vanguard Total Stock Mkt Idx Inv | 1.88M | 2.64% | 276.54K |
| Fidelity Small Cap Growth | 1.52M | 2.06% | - |
| iShares Russell 2000 ETF | 1.48M | 2.01% | - |
| Fidelity Select Health Care | 1.28M | 1.75% | -60.00K |
| Strategic Advisers Fidelity US TtlStk | 1.12M | 1.53% | 385.67K |
| Pictet-Biotech P USD | 865.27K | 1.18% | 98.59K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 19, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | $231.55K |
| Oct 19, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | $192.34K |
| Oct 01, 2026 | Garland J. Scott | - | Sell | $606.72K |
| Sep 17, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | $111.27K |
| Sep 17, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | $14.88K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q4 | - | 3 |
| 2026 Q3 | - | 23 |
| 2026 Q2 | - | 21 |
| 2026 Q1 | - | 21 |
| 2025 Q4 | - | 11 |
ELVN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools